CareDx, Inc. (CDNA)
CareDx provides transplant testing, donor matching products, software and pharmacy services for transplant centers and patients. It last closed at $74.56 on Nov 17, up 1.14% on the day. The average 12-month price target from 3 analysts is $90.67 (+21.6% from the last close), with a high of $100.00 and a low of $80.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in CDNA, 0% of them bullish and 100% bearish.
Key Stats
Last 12 monthsNot reported for this period.
From CDNA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 3 analysts who set a price target on CDNA in the past 90 days. The average target is $90.67, with a high of $100.00 and a low of $80.00, compared with the last close of $74.56.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 11 | Piper Sandler | Initiated | Buy | $100 |
| Oct 30 | BTIG | Target raised | Buy | $81 → $92 |
| Oct 27 | BTIG | Target raised | Buy | $74 → $81 |
| Oct 19 | Canaccord Genuity | Target raised | Buy | $65 → $80 |
| Sep 24 | BTIG | Target raised | Buy | $60 → $74 |
Technical Analysis
The stock sits between its 20 and 50 day averages. It is 50% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 50). The nearest support is the Pivot at $74.05, and the nearest resistance the Pivot R1 at $75.95.
| RSI (14) | 50.20 | Middle of its range | Neutral |
| MACD | 3.06 | Below its signal line | Bearish |
| Stochastic | 28.4 | Middle of its range | Neutral |
| ADX (14) | 39.8 | Trending up | |
| Williams %R | -78.0 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | -40.0 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −15.7% | Change over 10 sessions | Bearish |
| ATR (14) | $5.03 | Typical daily range, 6.7% of price |
| RSI (14) | 70.29 | Overbought above 70 | Overbought |
| MACD | 13.03 | Above its signal line | Bullish |
| Stochastic | 69.9 | Middle of its range | Neutral |
| ADX (14) | 72.8 | Strong uptrend | |
| Williams %R | -35.4 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 90.5 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +48.4% | Change over 10 sessions | Bullish |
| ATR (14) | $7.45 | Typical daily range, 10.0% of price |
What happened before
See how CDNA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How CDNA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.
Whale Options Flow
90DNo whale options trades in CDNA in the last 90 days.
CDNA Institutional Ownership
Full report →- ▲193 buying vs 110 selling
- ▼Held by funds -2.7 pts
- ▲Funds holding +79
- ▲Superinvestors: 4 added, 1 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 308 | 229 | +34.5% |
| In funds' top 10 | 5 | 4 | +25.0% |
| Held by funds | 99.0% | 101.6% | −2.7 pts |
| New / increased | 102 / 91 | 52 / 76 | +50.8% |
| Reduced / sold out | 87 / 23 | 68 / 13 | +35.8% |
| Put/call ratio | 0.00 | – | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CDNA is in one of them and how their past CDNA trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered CDNA in an article yet. Here's the latest on the wider market.
CDNA Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Dan GoldmanD · NY | Sell | $1K – $15K | Mar 6, 2023 | Apr 17, 2023 | 42 d |
| Tom MalinowskiD · NJ | Buy | $15K – $50K | Mar 2, 2021 | Apr 10, 2021 | 39 d |
| Tom MalinowskiD · NJ | Sell | $1K – $15K | Jun 19, 2019 | Mar 5, 2021 | 625 d |
| Tom MalinowskiD · NJ | Sell | $1K – $15K | Jun 17, 2019 | Mar 5, 2021 | 627 d |
| Tom MalinowskiD · NJ | Buy | $1K – $15K | Apr 1, 2019 | Mar 5, 2021 | 704 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About CareDx
CareDx is a company that offers testing and software for transplant patients and the clinicians who treat them. Its tests check heart, kidney and lung transplant recipients for signs of organ rejection after surgery. The company also sells products that help match donors and recipients before a transplant, software that helps transplant centers manage patient lists and workflow, and specialized pharmacy services for transplant patients. Its main customers are transplant centers, and it is based in Brisbane, California.
- Headquarters
- Brisbane, CA
- Founded
- 2000
- Website
- caredx.com ↗






